Skip to main content

Table 6 Absolute frequency of missing daily AH, MP values, and daily UF-DBD scores per patient

From: Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies

Patient group Number of patients Average number of days in period Mean SD Median IQR (Q1-Q3) Min-Max
Screening period
Patients with AH measurements
  Daily AH values 241 28 3.1 3.7 2.0 0.0–5.0 0.0–21.0
  Daily MP values 241 28 2.8 3.6 1.0 0.0–4.0 0.0–19.0
  Daily UF-DBD scores 241 28 2.8 3.5 1.0 0.0–4.0 0.0–21.0
US Patients with AH measurements
  Daily AH values 92 28 4.6 4.3 3.5 1.0–6.5 0.0–21.0
  Daily MP values 92 28 4.1 4.2 3.0 1.0–6.0 0.0–19.0
  Daily UF-DBD scores 92 28 4.3 4.2 3.5 1.0–6.0 0.0–21.0
28 days prior to and including EOT
Patients with AH measurements
  Daily AH values 223 28 3.2 4.1 2.0 0.0–4.0 0.0–21.0
  Daily MP values 223 28 3.0 4.0 2.0 0.0–4.0 0.0–21.0
  Daily UF-DBD scores 223 28 2.9 3.8 2.0 0.0–4.0 0.0–21.0
US Patients with AH measurements
  Daily AH values 82 28 5.0 4.9 4.0 2.0–7.0 0.0–21.0
  Daily MP values 82 28 4.8 4.7 4.0 1.0–7.0 0.0–21.0
  Daily UF-DBD scores 82 28 4.6 4.4 4.0 1.0–6.0 0.0–21.0
  1. The patient group analyzed here refers to those who had AH measurements from any study center. Patients from Japan were excluded as they were not asked to collect sanitary items for the AH method
  2. AH Alkaline hematin method, EOT End of treatment, IQR Interquartile range, Max Maximum, Min Minimum, MP (MP SAP-c v3) Menstrual pictogram superabsorbent polymer-containing version 3, N Number of patients, UF-DBD Uterine Fibroid Daily Bleeding Diary